Cargando…

Tu1554: A NOVEL METHOD FOR COLLECTING MICROBIOME SPECIMENS

Detalles Bibliográficos
Autores principales:	Rahimian, Pejman, Lee, Shaoying N., Quintana, Nelson, Wahl, Chris, Smith, Jeffrey, Case, Jacob, Singh, Sharat
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AGA Institute. Published by Elsevier Inc. 2022
Materias:	AGA Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212317/ http://dx.doi.org/10.1016/S0016-5085(22)62392-8

Ejemplares similares

Tu1544: HUMORAL AND T CELL RESPONSES TO COVID-19 VACCINATION IN INFLAMMATORY BOWEL DISEASE
por: Zhang, Eva, et al.
Publicado: (2022)

Tu1110: EXPRESSION OF EPITHELIAL PROTEASES PREDICTS SARS-COV-2 ENTRY IN HUMAN ENTEROIDS
por: Alvarado, David M., et al.
Publicado: (2022)

Tu1552: PRESERVED SARS-COV-2 VACCINE CELL-MEDIATED IMMUNOGENICITY IN INFLAMMATORY BOWEL DISEASE PATIENTS ON IMMUNEMODULATING THERAPIES
por: Boland, Brigid S., et al.
Publicado: (2022)

Tu1041: EFFECT OF TIMING PROTOCOL ON AFTER-HOURS ENDOSCOPY FOR FOREIGN BODY INGESTIONS AND ESOPHAGEAL IMPACTIONS
por: Karb, Daniel B., et al.
Publicado: (2022)

Tu1547: COVID-19 VACCINE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS
por: Meybodi, Mohamad Aghaie, et al.
Publicado: (2022)

Tu1033: IMPACT OF GERD ON PATIENTS UNDERGOING LUNG TRANSPLANTION FOR COVID-19: A SINGLE INSTITUTION RETROSPECTIVE STUDY
por: Kim, Christopher, et al.
Publicado: (2022)

Tu1108: INTERVAL CANCERS IN PATIENTS WITH HEREDITARY GASTROINTESTINAL SYNDROMES AFTER ONE YEAR OF THE SARS-COV-2 PANDEMIC
por: Barchi, Alberto, et al.
Publicado: (2022)

Tu1550: REAL WORLD USE AND ADVERSE EVENTS OF SARS-COV-2 VACCINATION IN GREEK PATIENTS WITH INFLAMMATORY BOWEL DISEASE
por: Orfanoudaki, Eleni, et al.
Publicado: (2022)

Tu1553: SPECIFIC IMMUNOGLOBLIN A INDUCED BY THE PERSISTENT COLONIZATION OF ADHERENT-INVASIVE E.COLI LIMITS PATHOBINT LOCALIZATION TO THE EPITHELIAL NICHE
por: Imai, Jin, et al.
Publicado: (2022)

Tu1040: COMPARATIVE EFFECTIVENESS OF VIRTUAL VS. IN-PERSON VISITS IN THE INITIAL EVALUATION OF ABDOMINAL PAIN PRIOR TO AND DURING THE COVID-19 PANDEMIC.
por: Sasankan, Priya, et al.
Publicado: (2022)

Tu1548: IMMUNE RESPONSE AFTER COVID-19 VACCINATION DURING MAINTANACE THERAPY IN IMMUNE-MEDIATED INFLAMMATORY DISEASES: AN OBSERVATIONAL COHORT STUDY
por: Dayam, R.M., et al.
Publicado: (2022)

Tu1549: IMPLEMENTATION AND SHORT-TERM ADVERSE EVENTS OF ANTI-SARSCOV-2 VACCINES IN INFLAMMATORY BOWEL DISEASE PATIENTS: AN INTERNATIONAL WEB-BASED SURVEY
por: Revés, Joana, et al.
Publicado: (2022)

Tu1546: JAPAN PROSPECTIVE MULTICENTER STUDY FOR OPTIMIZATION OF COVID-19 VACCINATIONS BASED ON THE IMMUNE RESPONSE AND SAFETY PROFILE IN INFLAMMATORY BOWEL DISEASE PATIENTS: INTERIM ANALYSES
por: Watanabe, Kenji, et al.
Publicado: (2022)

Tu1109: ENDOTHELIAL CELLS AND BLOOD VESSELS – CRITICAL TARGETS FOR COVID-19-INDUCED TISSUE INJURY AND SPREAD TO DISTANT ORGANS. UNDERLYING MECHANISMS INCLUDE ENDOTHELIAL DYSFUNCTION AND INJURY
por: Ahluwalia, Amrita, et al.
Publicado: (2022)

Tu1551: PATIENTS WITH INFLAMMATORY BOWEL DISEASES HAVE IMPAIRED ANTIBODY PRODUCTION AFTER ANTI-SARS-COV-2 VACCINATION, ESPECIALLY THOSE ON ANTI-TNFα OR COMBINATION TREATMENT OF BIOLOGICS PLUS IMMUNOMODULATORS: RESULTS FROM A PANHELLENIC REGISTRY
por: Zacharopoulou, Eirini, et al.
Publicado: (2022)

Fr580 THE MICROBIOME AND SARS-COV-2: DAVID VERSUS A TINY GOLIATH
por: Hazan, Sabine, et al.
Publicado: (2021)

Mo1020: GUT MICROBIOME CHANGES ASSOCIATED WITH HIGHER AND LONGER-LASTING ANTIBODY TITERS FOLLOWING COVID-19 VACCINATION
por: Venzon, Mericien M., et al.
Publicado: (2022)

Fr579 THE GUT MICROBIOME OF COVID-19 RECOVERED PATIENTS RETURNS TO UNINFECTED STATUS IN A MINORITY-DOMINATED UNITED STATES COHORT
por: Newsome, Rachel C., et al.
Publicado: (2021)

Fr136 CENTER-BASED EXPERIENCES IMPLEMENTING STRATEGIES TO REDUCE RISK OF HORIZONTAL TRANSMISSION OF SARS-COV-2: POTENTIAL FOR COMPROMISE OF NEONATAL MICROBIOME ASSEMBLAGE
por: Romano-Keeler, Joann, et al.
Publicado: (2021)

Su1073: SCREENING COLONOSCOPY REFERRALS DURING THE SARS-COV-2 PANDEMIC: IMPACT OF GASTROENTEROLOGIST RECOMMENDATION FOR FECAL IMMUNOHISTOCHEMICAL TESTING AS A PREFERRED COLORECTAL CANCER SCREENING METHOD AT A VA HEALTHCARE SYSTEM
por: Porter, Michael, et al.
Publicado: (2022)

Fr576 ORAL BACTERIOTHERAPY IN PATIENTS WITH COVID-19: A RETROSPECTIVE COHORT STUDY
por: Marazzato, Massimiliano, et al.
Publicado: (2021)

1160: PERCUTANEOUS GASTROSTOMY PLACEMENT IN PATIENTS WITH COVID-19 INFECTION: CLINICAL OUTCOMES AND THE INFREQUENT NEED FOR LONG-TERM ENTERAL ACCESS
por: Levine, Irving, et al.
Publicado: (2022)

Sa112 VENTILATED N95 RESPIRATORS REDUCE CO2 REBREATHING AND HAVE BETTER ACCEPTABILITY
por: Chesta, Fnu, et al.
Publicado: (2021)

427 AEROSOL MODELING AND MITIGATION STRATEGIES
por: Jaruvongvanich, Veeravich, et al.
Publicado: (2021)

Sa1300: VENOUS THROMBOEMBOLISM IS COMMON IN PATIENTS WITH ACUTE NECROTIZING PANCREATITIS AND IS ASSOCIATED WITH WORSE CLINICAL OUTCOMES: RESULTS OF A MULTICENTER ELECTRONIC HEALTH RESEARCH NETWORK STUDY
por: Singh, Ritu R., et al.
Publicado: (2022)

1166: IN-PATIENT ANTIBIOTIC EXPOSURE PROMOTES SARS-COV-2 PERSISTENCE IN THE GI TRACT IN COVID-19 ADMITTED PATIENTS
por: Sharma, Ashok, et al.
Publicado: (2022)

Sa1057: OUTCOMES AND MANAGEMENT OF ACUTE NECROTIZING PANCREATITIS DURING THE COVID-19 PANDEMIC
por: Smith, Zachary L., et al.
Publicado: (2022)

Su1500: COMPARATIVE EFFICACY AND SAFETY OF OZANIMOD AND USTEKINUMAB IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS
por: Dubinsky, Marla C., et al.
Publicado: (2022)

Sa126 TROPISM OF SARS-COV-2 FOR BARRETT'S ESOPHAGUS MAY INCREASE SUSCEPTIBILITY TO DEVELOPING COVID-19
por: Jin, Ramon, et al.
Publicado: (2021)

Fr501 BIOLOGICS AND COVID-19 OUTCOMES IN INFLAMMATORY BOWEL DISEASE PATIENTS
por: Weissman, Simcha, et al.
Publicado: (2021)

Sa1428: SARS-COV-2 INFECTION EVOKED HYPOALBUMINEMIA PREDICTS PROGRESSION TO CRITICAL ILLNESS IN PATIENTS WITH MILD TO SEVERE LIVER DISEASE
por: Nora, Ian, et al.
Publicado: (2022)

329: BODY SURFACE GASTRIC MAPPING DEFINES NEUROMUSCULAR DYSFUNCTION IN PATIENTS WITH NAUSEA AND VOMITING SYNDROMES
por: Calder, Stefan S., et al.
Publicado: (2022)

Fr089 IMPACT OF COVID-19 ON PANDEMIC MAJOR GASTROENTEROLOGY PROCEDURES, VISITS, AND NEW DIAGNOSIS OF GASTROINTESTINAL CANCERS
por: Khan, Ahmad, et al.
Publicado: (2021)

112 IMPACT OF COVID-19 INFECTION AMONG PATIENTS WITH PRE-EXISTING GASTROINTESTINAL CANCERS IN THE UNITED STATES: A MULTICENTER RESEARCH NETWORK STUDY.
por: Khan, Ahmad, et al.
Publicado: (2021)

Fr012 THE OBSERVED RISK OF RECURRENT BLEEDING AND THROMBOEMBOLIC DISEASE IN COVID-19 PATIENTS WITH GASTROINTESTINAL BLEEDING.
por: Attah, Emmanuel O., et al.
Publicado: (2021)

Fr500 COVID-19 IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: SYSTEMATIC REVIEW AND META-ANALYSIS
por: Tripathi, Kartikeya, et al.
Publicado: (2021)

Sa503 MACHINE LEARNING OUTPERFORMS TRADITIONAL RISK MODEL IN IDENTIFYING HIGH-NEED, HIGH-COST PATIENTS WITH INFLAMMATORY BOWEL DISEASES IN A NATIONALLY REPRESENTATIVE COHORT
por: Nguyen, Nghia H., et al.
Publicado: (2021)

Mo1087: MALADAPTIVE BEHAVIORS IN PERSONS WITH IBD DURING THE COVID-19 PANDEMIC
por: Shaffer, Seth R., et al.
Publicado: (2022)

Mo1086: MENTAL HEALTH IN IBD DURING THE COVID-19 PANDEMIC: ACCESS TO MENTAL HEALTH CARE AND EXPOSURE TO PANDEMIC NEWS
por: Shaffer, Seth R., et al.
Publicado: (2022)

Sa1055: PERCEPTIONS OF ACCESSING CARE AMONG IBD PATIENTS DURING THE COVID-19 PANDEMIC
por: Shaffer, Seth R., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3a4cp8vjrfje7dui00geprk39h